Skip to content
Governance Register

← US public companies

Terns Pharmaceuticals, Inc.

SEC CIK 1831363 · TERN · last insider filing 2026-05-05

Directors (from insider filings)

NameCapacity as filedFilings
Fellows David A Director filed 2021 - 2026
Kindler Jeffrey B Director filed 2021 - 2026
Turner Heather D Director filed 2024 - 2026
Azelby Robert Director filed 2025 - 2026
Tripuraneni Radhika Director filed 2022 - 2026
Quigley Jill M. Director · Sr. Advisor & Strategy Officer filed 2021 - 2026
Burroughs Amy L. Director · Chief Executive Officer filed 2024 - 2026
Lu Hongbo Director filed 2021 - 2025
Orbimed Advisors LLC Director filed 2021 - 2024
Gordon Carl L Director filed 2021 - 2024
Orbimed Capital GP VII LLC Director filed 2021 - 2024
Orbimed Genesis GP LLC Director filed 2022 - 2024
Orbimed Asia GP III, L.P. Director filed 2021 - 2024
Orbimed Advisors III Ltd Director filed 2021 - 2024
Taylor Ann Elizabeth Director filed 2021 - 2024
Sundaram Senthil Vel Director · Chief Executive Officer filed 2021 - 2023
Zhong Weidong Director · Chief Scientific Officer filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Gengos Andrew Chief Financial Officer filed 2025 - 2026
Kuriakose Emil Chief Medical Officer filed 2024 - 2026
Strauss David Eric Principal Accounting Officer filed 2025 - 2025
Jung Melita Sun Chief Business Officer filed 2024 - 2025
Vignola Mark J. Chief Financial Officer filed 2021 - 2025
Yoon Seokho Bryan See Remarks filed 2021 - 2024
Quirk Erin See Remarks filed 2021 - 2024
Russell Kerry Strong Chief Medical Officer filed 2022 - 2022

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.